By Josh Beckerman
Regeneron Pharmaceuticals Inc.'s Covid-19 antibody cocktail has received an expanded Emergency Use Authorization from the Food and Drug Administration.
The expanded authorization enables use of REGEN-COV for post-exposure prophylaxis in certain people exposed to a SARS-CoV-2 infected individual, or who are at high risk of exposure to an infected person in an institutional setting.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
07-30-21 1413ET